AdvanSix (NYSE:ASIX – Get Free Report) is projected to post its quarterly earnings results before the market opens on Friday, February 21st. Analysts expect AdvanSix to post earnings of ($0.37) per share and revenue of $377.15 million for the quarter. Individual that are interested in registering for the company’s earnings conference call can do so using this link.
AdvanSix Stock Performance
Shares of NYSE:ASIX opened at $29.76 on Friday. The firm has a market capitalization of $795.48 million, a PE ratio of 21.11 and a beta of 1.76. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.34 and a quick ratio of 0.62. The business has a 50-day moving average of $29.85 and a two-hundred day moving average of $29.63. AdvanSix has a 12 month low of $20.86 and a 12 month high of $33.00.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on the company. Piper Sandler increased their target price on AdvanSix from $35.00 to $39.00 and gave the company an “overweight” rating in a research note on Friday, November 8th. StockNews.com upgraded AdvanSix from a “hold” rating to a “buy” rating in a research note on Wednesday, December 4th.
Insider Buying and Selling at AdvanSix
In related news, Director Donald P. Newman bought 5,030 shares of the firm’s stock in a transaction that occurred on Monday, November 18th. The shares were acquired at an average cost of $29.64 per share, for a total transaction of $149,089.20. Following the acquisition, the director now directly owns 5,030 shares of the company’s stock, valued at $149,089.20. The trade was a ∞ increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Erin N. Kane sold 5,000 shares of AdvanSix stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $28.15, for a total value of $140,750.00. Following the completion of the transaction, the chief executive officer now owns 507,795 shares in the company, valued at $14,294,429.25. The trade was a 0.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 11,951 shares of company stock valued at $354,132 in the last quarter. Corporate insiders own 5.60% of the company’s stock.
AdvanSix Company Profile
AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.
Featured Articles
- Five stocks we like better than AdvanSix
- How to Calculate Return on Investment (ROI)
- Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up
- How to Find Undervalued Stocks
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
Receive News & Ratings for AdvanSix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvanSix and related companies with MarketBeat.com's FREE daily email newsletter.